-
Something wrong with this record ?
Plasma membrane and nuclear phosphatidylinositol 4,5-bisphosphate signalling in cancer
A. Chytła, S. Rattay, B. Akgül, M. Sztacho
Language English Country England, Great Britain
Document type Journal Article, Review
Grant support
Fond F Program
Charles University
Cooperatio Program: research area "Oncology and Haematology"
Charles University
AK 42/10-1
German Research Foundation
NPO EXCELES, ID Project No. LX22NPO5102
National Institute for Cancer Research
NLK
BioMedCentral
from 2002-12-01
BioMedCentral Open Access
from 2002
Directory of Open Access Journals
from 2002
Free Medical Journals
from 2002
PubMed Central
from 2002
Europe PubMed Central
from 2002
ProQuest Central
from 2009-01-01
Open Access Digital Library
from 2002-09-01
Open Access Digital Library
from 2002-01-01
Open Access Digital Library
from 2002-01-01
Medline Complete (EBSCOhost)
from 2002-09-03
Health & Medicine (ProQuest)
from 2009-01-01
ROAD: Directory of Open Access Scholarly Resources
from 2002
Springer Nature OA/Free Journals
from 2002-12-01
- MeSH
- Cell Membrane * metabolism MeSH
- Cell Nucleus * metabolism MeSH
- Phosphatidylinositol 4,5-Diphosphate * metabolism MeSH
- Humans MeSH
- Membrane Microdomains metabolism MeSH
- Neoplasm Metastasis MeSH
- Neoplasms * metabolism pathology genetics MeSH
- Signal Transduction * MeSH
- Animals MeSH
- Check Tag
- Humans MeSH
- Animals MeSH
- Publication type
- Journal Article MeSH
- Review MeSH
The development of metastasis is a leading cause of cancer-related death that involves specific changes in the plasma membrane (PM) and nucleus of cancer cells. Elevated levels of membrane lipids, including sphingomyelin, cholesterol, and phosphatidylinositol 4,5-bisphosphate (PI(4,5)P2), in the PM, contribute to changes in membrane rigidity, lipid raft formation, and actin polymerisation dynamics, processes that drive cell invasion. This review discusses the relationship between well-studied cytoplasmic phosphoinositides and their lesser-known nuclear counterparts, highlighting their functional role in metastatic progression. Nuclear phosphoinositides, particularly PI(4,5)P2, are essential for regulating transcription factors and chromatin organisation, thereby shaping gene expression patterns. We also explore the role of PI(4,5)P2 and its metabolism in cancer cell invasiveness and metastasis, proposing a model in which the dysregulation of cytosolic and/or nuclear PI(4,5)P2 pool triggers malignant transformation. Understanding the PI(4,5)P2-related mechanisms underlying metastasis may provide insights into potential therapeutic targets, paving the way for more effective therapies and improved patient outcomes.
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc25009926
- 003
- CZ-PrNML
- 005
- 20250429134959.0
- 007
- ta
- 008
- 250415s2025 enk f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1186/s12944-025-02452-6 $2 doi
- 035 __
- $a (PubMed)39915829
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a enk
- 100 1_
- $a Chytła, Agnieszka $u Laboratory of Cancer Cell Architecture, Institute of Biochemistry and Experimental Oncology, First Faculty of Medicine, Charles University, Prague, 128 00, Czech Republic
- 245 10
- $a Plasma membrane and nuclear phosphatidylinositol 4,5-bisphosphate signalling in cancer / $c A. Chytła, S. Rattay, B. Akgül, M. Sztacho
- 520 9_
- $a The development of metastasis is a leading cause of cancer-related death that involves specific changes in the plasma membrane (PM) and nucleus of cancer cells. Elevated levels of membrane lipids, including sphingomyelin, cholesterol, and phosphatidylinositol 4,5-bisphosphate (PI(4,5)P2), in the PM, contribute to changes in membrane rigidity, lipid raft formation, and actin polymerisation dynamics, processes that drive cell invasion. This review discusses the relationship between well-studied cytoplasmic phosphoinositides and their lesser-known nuclear counterparts, highlighting their functional role in metastatic progression. Nuclear phosphoinositides, particularly PI(4,5)P2, are essential for regulating transcription factors and chromatin organisation, thereby shaping gene expression patterns. We also explore the role of PI(4,5)P2 and its metabolism in cancer cell invasiveness and metastasis, proposing a model in which the dysregulation of cytosolic and/or nuclear PI(4,5)P2 pool triggers malignant transformation. Understanding the PI(4,5)P2-related mechanisms underlying metastasis may provide insights into potential therapeutic targets, paving the way for more effective therapies and improved patient outcomes.
- 650 _2
- $a lidé $7 D006801
- 650 12
- $a fosfatidylinositol-4,5-difosfát $x metabolismus $7 D019269
- 650 12
- $a buněčná membrána $x metabolismus $7 D002462
- 650 12
- $a nádory $x metabolismus $x patologie $x genetika $7 D009369
- 650 12
- $a signální transdukce $7 D015398
- 650 12
- $a buněčné jádro $x metabolismus $7 D002467
- 650 _2
- $a zvířata $7 D000818
- 650 _2
- $a membránové mikrodomény $x metabolismus $7 D021962
- 650 _2
- $a metastázy nádorů $7 D009362
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a přehledy $7 D016454
- 700 1_
- $a Rattay, Stephanie $u Institute of Virology, Medical Faculty, University of Cologne, University Hospital Cologne, 50935, Cologne, Germany
- 700 1_
- $a Akgül, Baki $u Institute of Virology, Medical Faculty, University of Cologne, University Hospital Cologne, 50935, Cologne, Germany $u National Reference Center for Papilloma- and Polyomaviruses, Institute of Virology, Faculty of Medicine, University Hospital Cologne, University of Cologne, 50935, Cologne, Germany
- 700 1_
- $a Sztacho, Martin $u Laboratory of Cancer Cell Architecture, Institute of Biochemistry and Experimental Oncology, First Faculty of Medicine, Charles University, Prague, 128 00, Czech Republic. martin.sztacho@lf1.cuni.cz
- 773 0_
- $w MED00008241 $t Lipids in health and disease $x 1476-511X $g Roč. 24, č. 1 (2025), s. 39
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/39915829 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y - $z 0
- 990 __
- $a 20250415 $b ABA008
- 991 __
- $a 20250429134954 $b ABA008
- 999 __
- $a ok $b bmc $g 2311354 $s 1247007
- BAS __
- $a 3
- BAS __
- $a PreBMC-MEDLINE
- BMC __
- $a 2025 $b 24 $c 1 $d 39 $e 20250206 $i 1476-511X $m Lipids in health and disease $n Lipids Health Dis $x MED00008241
- GRA __
- $a Fond F Program $p Charles University
- GRA __
- $a Cooperatio Program: research area "Oncology and Haematology" $p Charles University
- GRA __
- $a AK 42/10-1 $p German Research Foundation
- GRA __
- $a NPO EXCELES, ID Project No. LX22NPO5102 $p National Institute for Cancer Research
- LZP __
- $a Pubmed-20250415